Cargando…

The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model

Detalles Bibliográficos
Autores principales:	Kargl, Julia, Haybäck, Johannes, Stančić, Angela A, Marsche, Gunther, Heinemann, Ákos, Schicho, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506320/ http://dx.doi.org/10.1186/2050-6511-13-S1-A23

Ejemplares similares

A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
por: Li, Kun, et al.
Publicado: (2013)

Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity
por: Simcocks, Anna C, et al.
Publicado: (2019)

An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
por: O'Donnell, Charlotte, et al.
Publicado: (2016)

The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity
por: Simcocks, Anna C., et al.
Publicado: (2020)

The anti‐parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice
por: Knuplez, Eva, et al.
Publicado: (2021)

Myeloperoxidase Alters Lung Cancer Cell Function to Benefit Their Survival
por: Cosic-Mujkanovic, Nejra, et al.
Publicado: (2023)

O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
por: Wróbel, Andrzej, et al.
Publicado: (2020)

IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils
por: Kienzl, Melanie, et al.
Publicado: (2020)

Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression
por: Pasterk, Lisa, et al.
Publicado: (2016)

Secretory phospholipase A(2) modified HDL rapidly and potently suppresses platelet activation
por: Curcic, Sanja, et al.
Publicado: (2017)

Lectins, Colitis and Colon Cancer
por: Rhodes, Jonathan M
Publicado: (2000)

DP1 receptor signaling prevents the onset of intrinsic apoptosis in eosinophils and functions as a transcriptional modulator
por: Peinhaupt, Miriam, et al.
Publicado: (2018)

Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
por: Kienzl, Melanie, et al.
Publicado: (2020)

PPARα Ligands as Antitumorigenic and Antiangiogenic Agents
por: Pozzi, Ambra, et al.
Publicado: (2008)

The Immune Endocannabinoid System of the Tumor Microenvironment
por: Kienzl, Melanie, et al.
Publicado: (2020)

Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8(+) T and NK cells
por: Sarsembayeva, Arailym, et al.
Publicado: (2023)

E-type prostanoid receptor 4 (EP4) in disease and therapy
por: Konya, Viktoria, et al.
Publicado: (2013)

The Antitumorigenic Function of EGFR in Metastatic Breast Cancer is Regulated by Expression of Mig6
por: Wendt, Michael K., et al.
Publicado: (2015)

Abstract: Antitumorigenic Effect of Deferoxamine on Human Head and Neck Cancer Cell Proliferation
por: Donneys, Alexis, et al.
Publicado: (2018)

Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging
por: Liang, Qian, et al.
Publicado: (2019)

Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells
por: Huang, Yi-Hsuan, et al.
Publicado: (2022)

1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial
por: Da Cruz Tomas, T.F., et al.
Publicado: (2021)

Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
por: Kerr, Lauren T., et al.
Publicado: (2016)

Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
por: Hasenoehrl, Carina, et al.
Publicado: (2017)

Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
por: Taschler, U, et al.
Publicado: (2015)

Acute necrotizing colitis due to sigmoid colon cancer
por: Matsunaga, Hiroki, et al.
Publicado: (2014)

Mass-forming ischemic colitis that mimics colon cancer
por: Kim, Ho Seung, et al.
Publicado: (2020)

Ischemic Colitis or Colon Cancer: A Diagnostic Dilemma
por: Khanal, Sneha, et al.
Publicado: (2023)

A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors
por: Wróbel, Andrzej, et al.
Publicado: (2020)

Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo
por: Ray, Jocelyn E., et al.
Publicado: (2021)

Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 Production
por: Becker, William, et al.
Publicado: (2020)

Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
por: Marsche, Gunther, et al.
Publicado: (2022)

Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells
por: YAMAMURO, SHUN, et al.
Publicado: (2015)

Abstract 105: Deferoxamine: A Regenerative Therapeutic with Antitumorigenic Potential
por: Donneys, Alexis, et al.
Publicado: (2018)

The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer
por: Benedicto, Aitor, et al.
Publicado: (2022)

Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer
por: Dasgupta, Aneesha, et al.
Publicado: (2022)

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
por: Stolfi, Carmine, et al.
Publicado: (2011)

Hemorrhagic Cytomegalovirus Colitis in a Postoperative Colon Cancer Patient
por: Saito, Motonobu, et al.
Publicado: (2013)

Hemidesmosome integrity protects the colon against colitis and colorectal cancer
por: De Arcangelis, Adèle, et al.
Publicado: (2017)

Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer
por: Jeon, Myeongjin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6bsu1gcq97k98vjhod08m2m7r5